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Abstract

In an effort to probe the role of the Zn(II) sites in metallo-β-lactamase L1,
mononuclear metal ion containing and heterobimetallic analogues of the
enzyme were generated and characterized using kinetic and spectroscopic
studies. Mononuclear Zn(II)-containing L1, which binds Zn(II) in the
consensus Zn1 site, was shown to be slightly active; however, this enzyme did
not stabilize a nitrocefin-derived reaction intermediate that had been
previously detected. Mononuclear Co(II)- and Fe(III)-containing L1 were
essentially inactive, and NMR and EPR studies suggest that these metal ions
bind to the consensus Zn2 site in L1. Heterobimetallic analogues (ZnCo and
ZnFe) analogues of L1 were generated, and stopped-flow kinetic studies
revealed that these enzymes rapidly hydrolyze nitrocefin and that there are
large amounts of the reaction intermediate formed during the reaction. The
heterobimetallic analogues were reacted with nitrocefin, and the reactions
were rapidly freeze quenched. EPR studies on these samples demonstrate
that Co(II) is 5-coordinate in the resting state, proceeds through a 4coordinate species during the reaction, and is 5-coordinate in the
enzyme−product complex. These studies demonstrate that the metal ion in
the Zn1 site is essential for catalysis in L1 and that the metal ion in the Zn 2
site is crucial for stabilization of the nitrocefin-derived reaction intermediate.

Introduction
β-Lactam-containing compounds are the most widely used
antibiotics, and they exert their antimicrobial activity by inhibiting the
cross-linking of the peptidoglycan building blocks of bacterial cell
walls.1 Ever since the introduction of these antibiotics in the clinic,
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there has been an increasing number of bacterial strains that are
resistant to these drugs. The most common way that bacteria become
resistant to β-lactams is through the production of β-lactamases,
which cleave the β-lactam bond and inactivate the drug.2 There are
500 known β-lactamases, and these enzymes have been classified into
four groups.3 Although groups A, C, and D exhibit different substrate
specificities and susceptibilities to clinical inhibitors, they are similar in
the fact that they utilize an active-site serine as a nucleophile to attack
the β-lactam carbonyl, generating a tetrahedral intermediate.1 The
group B enzymes, on the other hand, require 1−2 Zn(II) ions to
hydrolyze β-lactams and thus are called metallo-β-lactamases (Mβls).4
Mβls have been further categorized into three subgroups according to
amino acid homology, substrate preference, and the number of Zn(II)
ions required for full activity. The B1 subgroup, represented by CcrA,
BcII, and IMP-1, have two metal binding sites: Zn1, which consists of
three histidines and a bridging hydroxide to coordinate Zn(II), and
Zn2, which consists of one histidine, one aspartate, one cysteine, the
bridging hydroxide, and a terminally bound H2O to coordinate Zn(II).
The B2 enzymes, represented by CphA and ImiS, bind Zn(II) at the
consensus Zn2 site, which contains one histidine, one aspartate, one
cysteine, and a solvent molecule to coordinate Zn(II). The B3
enzymes, represented by L1 and FEZ, bind two Zn(II) ions, contain the
same Zn1 site as the B1 enzymes, and utilize a Zn2 site, which consists
of two histidines, one aspartate, one terminally bound water, and the
bridging hydroxide. Recently, a B2/B3 hybrid, metallo-β-lactamase
GOB from Elizabethkingia meningoseptica, binds only 1 Zn(II) in the
Zn2 site.5
There exists considerable controversy about the metal content
of the nominally dinuclear Zn(II)-containing (B1 and B3) Mβl’s. The
initial crystal structure of BcII showed a single Zn(II) ion in the Zn1
site of the enzyme;6 however, subsequent structures have shown a
dinuclear Zn(II) site in BcII.7,8 Similar conflicting data on the metal
content of L1, IMP-1, and CcrA have not been reported; however,
Wommer et al. used in vitro binding assays to predict that all Mβl’s are
metal-free in vivo and become mononuclear enzymes only in the
presence of substrate.9 Wommer et al. continued by concluding that
dinuclear Zn(II)-containing Mβl’s are isolation artifacts. Nonetheless,
Page and co-workers have recently reported that BcII containing only
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one equivalent of Co(II) is inactive, and the loss of metal ion during
catalysis is the reason for the burst kinetics exhibited by this
enzyme.10-12 In constrast, Vila and co-workers have recently published
that the BcII containing only one equivalent of Zn(II) is catalytically
active13,14 and that B3 subgroup member, GOB, requires only a single
metal ion in the Zn2 to be active, analogous to the B2 enzymes.5
The metal ion binding characteristics of L1, CcrA, and BcII have
been investigated and characterized.4,15 However, of much greater
interest is the nature of the metal ion complement that is required for
activity and the roles in catalysis, if any, of each of the metal ions that
can be accommodated by these enzymes. The study of mononuclear or
mixed-metal analogues of the enzymes provides one mechanism for
the elucidation of the role of each metal and to indicate whether one or
both are essential for activity. In addition, this information could be
used to guide rational drug design efforts that use the Zn1, Zn2, or
both sites as targets for inhibitors.
In this work, we describe the preparation and characterization of
mononuclear metal ion- and mixed-metal-containing analogues of Mβl
L1 from Stenotrophomonas maltophilia; kinetic, spectroscopic, and
spectrokinetic analyses of these species reveal roles for both metal
ions in catalysis.

Materials and Methods
Materials
Escherichia coli strains DH5α and BL21(DE3)pLysS were
purchased from Gibco BRL (Gaithesberg, MD) and Novagen (Madison,
WI), respectively. Plasmids pET26b(+) and pUC19 were purchased
from Novagen. Restriction enzymes, NcoI and HindIII,
deoxynucleotides (dNTPs), thermopol buffer, MgSO4, and T4 DNA
ligase were obtained from New England Biolabs (Beverly, MA),
Promega Corporation (Madison, WI), and Gibco BRL. QuikChange sitedirected mutagenesis kit was purchased from Stratagene. All
mutagenic primers were purchased from Integrated DNA Technologies
(IDT, Coralville, IA). Polymerase chain reaction (PCR) was performed
using a Thermolyne Amplitron II from Barnstead (Dubuque, IA). DNA
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purification was performed by using a Qiagen Quick Gel Extraction kit
(Velencia, CA). The QIAGEN-tip 100 kit and protocols were used for
large-scale plasmid purifications. A Wizard Plus Miniprep kit from
Promega was used for small-scale plasmid DNA preparations.
Luria−Bertani (LB) media was purchased from Invitrogen (Carlsbad,
CA). Isopropyl-β-d-thiogalactoside (IPTG) was purchased from
Anatrace (Maumee, OH). All buffer solutions were prepared using
chemicals purchased from Fisher Scientific (Pittsburgh, PA). All buffers
and growth media were made with Barnstead NANOpure, ultrapure
water. For metal-free solutions, Chelex 100 resin (Biorad Laboratories,
Hercules, CA) was used, and the resulting solutions were filtered
through a 0.45-μm filter membrane (Osmonic Inc.). Dialysis tubing
was prepared as per Sambrook et al.16 from Spectro/Por regenerated
cellulose, molecular porous membranes with a molecular weight cutoff
of 10,000 Da (Spectrum Corporation, Gardena, CA). A fast protein
liquid chromatography (FPLC) system, chromatography columns, and
resins were purchased from GE Healthcare. Nitrocefin was obtained
from Becton Dickinson Microbiology System (Cockeysville, MD), and
solutions of nitrocefin were prepared as previously described.17

Generation of Histidine Mutants of L1 by Site-Directed
Mutagenesis
The overexpression plasmids of four His→Cys L1 mutants,
H116C, H118C, H121C, and H196C were constructed using the L1
overexpression plasmid pET26b(+), which yields the full-length form
of the enzyme, and the QuikChange site-directed mutagenesis kit as
per the instructions of the manufacturer. The following primers were
used to generate the mutants:
H116Cfor
CGGCTGATCCTGCTCAGCTGCGCACACGCCGACCATGCC
H116Crev
GGCATGGTCGGCGTGTGCGCAGCTGAGCAGGATCAGCCG
H118Cfor
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ATCCTGCTCAGCCACGCATGCGCCGACCATGCCGGACCG
H118Crev
CGGTCCGGCATGGTCGGCGCATGCGTGGCTGAGCAGGAT
H121Cfor
CACGCACACGCCGACTGCGCCGGACCGGTGGCG
H121Crev
CGCCACCGGTCCGGCGCAGTCGGCGTGTGCGTG
H196Cfor
CACTTCATGGCGGGGTGCACCCCGGGCAGCACCGCG
H196Crev
CGCGGTGCTGCCCGGGGTGCACCCCGCCATGAAGTG
H225Cfor
GTGTTGCTGACACCGTGCCCGGGTGCCAGCAAC
H225Crev
GTTGCTGGCACCCGGGCACGGTGTCAGCAACAC

Overexpression of His→Cys Mutants
Large-scale preparations of His→Cys L1 mutants were
conducted by using the procedure of Crowder et al.17 L1 was
quantitated by monitoring the absorbance at 280 nm and using an
extinction coefficient of 54,600 M−1cm−1.17
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Preparation of 1Zn-, 1Co-, 1Fe-L1
Mature L1 (M-L1) was overexpressed as previously described by
adding 100 μM ZnCl2, CoCl2, or Fe(NH4)2(SO4)2 to the minimal
medium.18 After protein overexpression and centrifugation to collect
the E. coli cells, the pellet was resuspended in 300 mL of 50 mM
Hepes, pH 6.0, and the suspension was centrifuged for 15 min
(8200g). The resulting pellet was resuspended in 50 mM Hepes, pH
6.0, and the cells were lysed by using a French press as previously
described.17 The cleared supernatant (centrifugation for 25 min at
23,400g) was loaded onto a 25 mL SP-Sepharose column that was
equilibrated with 50 mM Hepes, pH 6.0, and bound proteins were
eluted from the column using a linear 0−500 mM NaCl gradient in the
same buffer. L1 typically eluted at 80−120 mM NaCl, and the fractions
were analyzed for the presence of L1 by using SDS-PAGE, as
previously described.17

Preparation of ZnCoL1, ZnFeL1, FeFeL1, and CoCoL1
samples
The ZnFe analogue of L1 was prepared by adding 3 equiv of
Zn(II) to as-isolated 1FeL1 or 3 equiv of Fe(II) to as-isolated 1ZnL1,
followed by dialysis against 4 × 1 L of Chelex-treated 50 mM Hepes,
containing 50 mM NaCl, to remove unbound metal. The ZnCo analogue
was prepared by adding 3 equiv of Zn(II) to 1CoL1. The FeFe and
CoCo analogues of L1 were prepared by refolding apo-L1 in the
presence of 100 μM Fe(II) or Co(II), as recently described.18

Metal Analyses
The metal content of the protein samples was determined by
using a Varian Liberty 150 inductively coupled plasma spectrometer
with atomic emission spectroscopy detection (ICP-AES). All the
proteins were diluted to 10 μM with 50 mM Hepes, pH 7.0. A
calibration curve with four standards and a correlation coefficient of
greater than 0.999 was generated using Zn(II), Fe, and Co(II)
reference solutions from Fisher Scientific. The following emission
wavelengths were chosen to ensure the lowest detection limits
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possible: Zn(II), 213.856 nm, Fe, 259.940 nm, and Co(II), 238.892
nm.
1

H NMR Spectroscopy

H NMR spectra were collected on a Bruker Avance 500
spectrometer operating at 500.13 MHz, 298 K, magnetic field of 11.7
T, recycle delay (AQ) of 41 ms, and sweep width of 400 ppm. Proton
chemical shifts were calibrated by assigning the H2O signal the value
of 4.70 ppm. A modified presaturation pulse sequence (zgpr) was used
to suppress the proton signals originating from solvent. The
presaturation pulse was as short as possible (500 ms) to avoid
saturation of solvent-exchangeable proton signals. The concentration
of NMR samples was generally in the range of 1.0−1.2 mM. Samples in
D2O were prepared by performing three or more dilution/concentration
cycles in a Centricon-10.
1

Rapid-Freeze-Quench (RFQ) and EPR Spectroscopy
L1 (0.5 mM) was reacted with 1.5 mM nitrocefin in 50 mM
cacodylate buffer, pH 7.0, and at 3 ± 1 °C, and the reaction mixture
was freeze-quenched for EPR spectroscopy using a system described in
earlier work19,20 the calibrated reaction time was 10.4 ± 0.5 ms.
Following EPR data collection, some samples were thawed by agitation
of the sample tubes in water at 25 °C for 2 min and refrozen in liquid
nitrogen. Low temperature EPR spectroscopy was carried out using a
Bruker EleXsys E600 spectrometer equipped with an Oxford
Instruments ITC503 liquid helium flow system. EPR was recorded at
9.63 GHz (B0⊥B1) or 9.37 GHz (B0∥B1) using an ER4116DM dual-mode
cavity, with 100 kHz magnetic field modulation. Other EPR recording
parameters are given in the legends to figures.

Steady-State Kinetics
All kinetic studies were conducted on a Agilent 8453 UV−vis
diode array spectrophotometer at 25 °C. Steady-state kinetic
parameters, the Michaelis constant Km and the turnover number kcat,
were determined by monitoring product formation at 485 nm using
nitrocefin as substrate in 50 mM Chelex-treated, cacodylate buffer, pH
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7.0. The rate of change in the absorbance at 485 nm was converted
into the rate of change in the concentration of the product by dividing
the absorbance (path length = 1 cm) by the extinction coefficient of
the product 17,420 M−1 cm−1.17

Stopped-Flow Kinetic Studies
Stopped-flow kinetic experiments were performed on an Applied
Photophysics SX18MV spectrophotometer equipped with a constanttemperature circulating water bath as previously described.21-23 All
experiments were performed in 50 mM Chelex-treated, cacodylate
buffer, pH 7.0, at 10 °C. All the proteins were diluted with 50 mM
Chelex-treated, cacodylate buffer to 100 μM, and the substrate was
prepared and diluted to 100 μM in the same buffer.

Results
Mutations of Metal Binding Histidines
Our previous attempts to prepare a mixed-metal analogue of L1
by adding Co(II) to apo- or 1Zn-L1 were unsuccessful primarily due to
the oxidation of Co(II) to Co(III).24 Another potential problem with
generating a mixed-metal analogue is the reported dissociation
constants for metal binding to the Zn1 and Zn2 sites in L1. Wommer et
al. reported that the Zn(II) binding constants to the two sites in L1 are
2.6 and 6 nM.9 This result suggests that the addition of different metal
ions to apo-L1 would result in sample with mixtures of possible metal
centers. Therefore, we attempted to prepare a mixed-metal analogue
of L1 by weakening one of the metal binding sites through mutation of
one of the histidine groups in each metal binding site. For example, we
reasoned that the mutation of His116 to Cys in the Zn1 site would
result in a mutant that binds the first added metal ion tightly to the
Zn2 site and the second metal ion much less tightly to the Zn1 site.
Five metal binding mutants of L1 (H116C, H118C, H121C,
H160C, and H263C) were successfully prepared using nondegenerate
oligonucleotides, the QuikChange Site Directed Mutagenesis kit, and
polymerase chain reaction. DNA sequencing of the resulting L1 genes
in both directions was used to confirm that only the desired mutations
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were present. Small-scale growth cultures showed that all five mutants
were overexpressed at levels comparable to that of wild-type L1.
However, large-scale (4 L) overexpression and purification of these
mutants showed that only the H116C and H121C mutants were soluble
and could be purified.
The purified mutants were analyzed for metal binding. After
purification, the H116C mutant was shown to bind 0.33 equiv of
Zn(II), while the H121C mutant bound 0.11 equiv of Zn(II) (Table 1).
The mutants were incubated with a 10 fold excess of Zn(II), and the
resulting enzymes were then exhaustively dialyzed versus Chelextreated buffer. Zn(II)-loaded H116C and H121C mutants were shown
to bind 0.85 and 0.98 equiv of Zn(II), respectively (Table 1), which is
one-half of the metal bound by recombinant wild-type L1. The asisolated and Zn(II)-loaded mutants were characterized by using
steady-state kinetic studies. As-isolated H116C and H121C mutants
exhibited kcat values of <0.01 s−1 when using nitrocefin as substrate;
however, the Zn(II)-loaded H116C and H121C mutants exhibited kcat
values of 0.38 and 2.3 s−1 and Km values of 20 and 72 μM,
respectively. The inclusion of 100 μM Zn(II) in the steady-state
kinetics assay buffer resulted in no change in the steady-state kinetic
constants for the H116C mutant and a kcat = 33 s−1 and a Km = 99 μM
for the H121C mutant, when using nitrocefin as the substrate. While
we were successful in preparing analogues of L1 with differential metal
binding affinities for the Zn1 and Zn2 sites, one of the mutants
exhibited very little activity (H116C), and the other exhibited a Km
value that suggested a large change in the active site of the enzyme
(H121C).
Table 1. Steady-State Kinetic Parameters and Metal Content of HXXC
Mutants of L1
mutant

kcat(s−1)

Km(μM)

Zn(II)content

H116Ca

<0.01

ND

0.33 ± 0.01

H121Ca

<0.01

ND

0.11 ± 0.01

H116Cb

0.38 ± 0.01

20 ± 1

0.85 ± 0.05

H121Cb

2.3 ± 0.2

72 ± 25

0.98 ± 0.05

H116Cc

0.35 ± 0.01

18 ± 1

NA

H121Cc

33 ± 4

99 ± 15

NA

4±1

1.90 ± 0.01

41 ± 1
as-isolated/wild-type L1c
aAs isolated.
bAfter adding 2 equiv of Zn(II) and then dialysis.
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cReaction

with 100 μM Zn(II) in buffer; ND - not determined; NA - not applicable.

Preparation and Characterization of the ZnCo-Analogue
of L1
Our initial attempts to prepare Co(II)-substituted L1 by
biological incorporation were unsuccessful because of the oxidation of
Co(II) to Co(III) presumably during protein purification.24 In these
studies, the gene for L1 contained a leader sequence that directed the
export of overexpressed L1 into the periplasm of E. coli, and our
recent studies strongly suggest that folding and metalation of L1
occurs in the periplasm.18 In this same study, we demonstrated that
the removal of the leader sequence from the L1 gene resulted in the
enzyme being folded and metallated in the cytoplasm of E. coli.
Significantly, the metal content of the resulting enzyme could be
affected greatly by the addition of metal ions in the growth medium.
In an effort to prepare a Co(II)-substituted form of L1, we
overexpressed L1 in minimal medium containing 100 μM CoCl2 using
the L1 gene without the leader sequence. The resulting, purified
enzyme (called 1Co-L1) was pink, and the color did not change up to
two months in 4 °C. Metal analyses revealed that the protein bound
0.9 equiv of cobalt and 0.1 equiv of Zn(II) (Table 2). Steady-state
kinetic studies revealed that the enzyme exhibited a kcat of 11 ± 1 s−1
and a Km of 4.3 ± 0.1 μM, when using nitrocefin as a substrate (Table
2). These steady-state kinetic constants are different than those of
ZnZn-L1 (kcat of 39 s−1; Km of 5.9 μM); 1Zn-L1 (kcat of 30 s−1; Km of 5.5
μM), and CoCo-L1 (kcat of 63 s−1; Km of 20 μM) (Table 2). In addition,
the kcat values exhibited by the mononuclear metal ion containing
analogues are not one-half of those exhibited by the dinuclear metal
ion-containing analogues, suggesting that the samples of mononuclear
metal ion-containing analogues are not made up of one-half dinuclear
metal ion-containing analogues and one-half apo-enzymes.
Table 2. Steady state kinetics of different metal bound analogues of L1
species

kcat(s−1)

Km(μM)

metal content

ZnZn-L1

39 ± 1

5.9 ± 0.5

2.0 ± 0.1 Zn(II) added

1Zn-L1

30 ± 1

5.5 ± 0.7

1.0 ± 0.1 Zn(II)

1Co-L1

11 ± 1

4.3 ± 0.1

0.9 ± 0.1 Co, 0.10 ± 0.01 Zn(II)

1Fe-L1

2.6 ± 1

53 ± 25

0.9 ± 0.1 Fe, 0.20 ± 0.01 Zn(II)
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species

kcat(s−1)

Km(μM)
20 ± 1

metal content

CoCo-L1a

63 ± 3

FeFe-L1a

0

ZnCo-L1

26 ± 0.3

2.3 ± 0.1

1.0 ± 0.1 Zn(II); 1.0 ± 0.1 Co

ZnFe-L1b

20 ± 2

3.6 ± 1

1.0 ± 0.1 Zn(II); 1.0 ± 0.1 Fe

N/A

1.80 ± 0.20 Co
1.90 ± 0.01 Fe

24 ± 3
4.0 ± 1
1.2 ± 0.1 Zn(II); 0.9 ± 0.1 Fe
from Hu et al.26
bFe added to Zn-L1 and then dialysis.
cZn(II) added to Fe-L1 and then dialysis.
ZnFe-L1c

aData

The UV−vis difference spectrum of 1Co-L1 revealed a broad,
weak peak between 500−650 nm (Figure 1A), which was assigned to
ligand field transitions of high-spin Co(II), and the extinction
coefficient at 550 nm was 130 M−1 cm−1, which suggests that the
Co(II) is 5-coordinate.25 This spectrum is different than that of CoCoL1, which was prepared by adding Co(II) to TCEP (tris(2carboxyethyl)phosphine)-treated apo-L1, in that there is no broad
absorbance peak between 330−360 nm corresponding to a S-to-Co(II)
ligand-to-metal charge transfer band.26 The addition of 1 equiv of
Zn(II) to 1Co-L1 did not change the UV−vis spectrum (Figure 1A).

Figure 1. UV−vis and NMR spectra of 1Co-L1. (A) UV−vis difference spectrum of 1CoL1 prepared using biological incorporation method. The enzyme concentration was 550
μM, and the buffer was 50 mM Hepes, pH 7.0. (B) 1H NMR spectrum of 550 μM 1CoL1. The asterisk signifies the peak that is solvent-exchangeable.
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exchangeable (Figure 1C). Since there are two histidines in the Zn2
site and three histidines in the Zn1 site,27 we assign these peaks to the
NH protons on Co(II)-bound His121 and His263, which indicates the
Co(II) is bound to the Zn2 site in L1. The addition of 1 equiv of Zn(II)
to 1Co-L1 did not change the NMR spectrum (Figure 1B).
Previously, we reported that 1Zn-L1 could be prepared by
addition of 1 equiv of Zn(II) to apo-L1, and this sample was
characterized with steady-state kinetics and EXAFS spectroscopy.28
The enzyme exhibited a kcat of 30 s−1 and a Km of 5.5 μM when using
nitrocefin as the substrate (Table 2), but we were uncertain whether
these constants reflected an enzyme sample that contained significant
amount of ZnZn-L1 due to the amounts of adventitious Zn(II) found in
buffers.9,29 The addition of Co(II) to 1Zn-L1 resulted in a pink
coloration that immediately turned orange in less than 10 s, indicating
oxidation of Co(II) to Co(III). On the other hand, the addition of Zn(II)
to 1Co-L1, which was prepared by the biological incorporation method
described above, resulted in a protein that remained pink in color. The
ZnCo-L1 (this notation indicates Zn(II) in the Zn1 site and Co(II) in the
Zn2 site) analogue of L1 exhibited a kcat of 26 s−1 and a Km of 2.3 μM,
when using nitrocefin as substrate. These values are similar to those of
1Zn-L1 and ZnZn-L1, and it is not possible with steady-state kinetics
alone to determine if the ZnCo-L1 analogue is responsible for the
observed activity.

EPR Spectroscopy of Metal-Ion-Substituted Forms of L1
EPR spectra of L1 with increasing Co(II) complement show a
complex but sequential pattern of Co(II) binding (Figure 2A−E). A
sample of nominally 1Co-L1 that was found to contain only 0.8 equiv
Co(II) exhibited an EPR spectrum (Figure 2A) that contained two
reasonably well-resolved components. A 59Co hyperfine pattern with A
= 9.8 × 10−3 cm−1, centered at 996 G (geff = 6.89), and a derivative
feature at 2320 G (geff = 2.97) were assigned to a rhombic species
with greal(⊥) = 2.55 and E/D = 0.27. The second species exhibited no
sharp resonances and was due to an axial species similar to that
observed from Co(II) in L1 in earlier work.20 Based on previous
reports, these signals are consistent with an equilibrium of Co(II)-H2O
and Co(II)-OH.30-32 More typically, 1Co-L1 contained 0.9−1.0 equiv
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Co(II), and the spectrum (Figure 2B) became less well-resolved, with
only inflection points to suggest the presence of the distinct species
observed at lower Co(II) complement. The spectrum of ZnCo-L1
(Figure 2C) was very similar to that of 1Co-L1 (Figure 2B), suggesting
that the presence of Zn(II) in either of the binding sites did not
significantly perturb the electronic structure of Co(II) in the remaining
sites. In contrast, the spectrum of 2Co-L1 (Figure 2D) was markedly
different from those of 1Co-L1 and ZnCo-L1; the spectrum could not
be simulated assuming even two distinct species, and spin-Hamiltonian
parameters could not be assigned. EPR absorption at very low field,
0−500 G, suggested the presence of a spin-coupled component in the
spectrum, and this was confirmed by parallel mode EPR (Figure 2E),
which revealed a resonance at geff ≈ 10, consistent with S′ = 2 and/or
S′ = 3 resonances in an S′ = 0, 1, 2, 3 spin ladder due to coupling of
two S = 3/2 Co(II) ions.

Figure 2. EPR spectra from metal-containing species of L1. Spectra are of the
following species of L1: (A) L1 containing 0.8 equiv Co(II) at 12 K, 25 mW; (B) 1Co-L1
at 12 K, 2 mW; (C) ZnCo-L1 at 10 K, 2 mW; (D) CoCo-L1 at 12 K, 10 mW; (E) CoCoL1 at 7 K, 20 mW, B0∥B1; (F) 1Fe-L1 at 10 K, 2 mW; (G) ZnFe-L1 at 12 K, 10 mW; (H)
FeFe-L1 at 10 K, 2 mW; (I) FeNi-L1 at 7 K, 50 mW; (J) FeCo-L1 at 10 K, 2 mW.
Spectra are shown with arbitrary intensities.
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Stopped-Flow Kinetic Studies on ZnCo-L1
The accurate interpretation of steady-state kinetic studies on
mixed-metal and mononuclear metal-containing analogues can be
complicated by the presence of adventitious Zn(II) in the assay
buffers. For example, typical steady-state kinetic studies contain 1−10
nM L1, and the amount of adventitious Zn(II) in buffers, even those
that have been Chelex-treated, can be between 10−100 nM.9,29
Therefore, it is probable that steady-state kinetic assays were
conducted with enzymes containing a mixture of possible metal
centers. Therefore, we characterized the mixed-metal analogues and
proteins containing only one metal ion with presteady-state kinetic
studies at or near single-turnover conditions (∼50 μM enzyme and ∼50
μM nitrocefin). The advantage of this approach is that the enzyme
concentrations in these samples are at least 2 orders of magnitude
higher than the concentration of adventitious Zn(II) in the buffer. This
approach also allowed us to monitor the role of each metal ion in
catalysis.
1Zn-L1 was prepared as described above. The stopped-flow
traces for 1Zn-L1 showed that substrate (absorbs at 390 nm) was
depleted within 1.3 s (Figure 3A) and that very little intermediate
(absorbs at 665 nm) was observed. The stopped-flow traces were
fitted to an exponential equation, and the rate of product formation
was 0.92 ± 0.03 s−1 (Table 3). In comparison, the stopped-flow trace
of ZnZn-L1 showed that substrate was depleted in 0.06 s and that a
significant amount of intermediate forms (Figure 3B). The rate of
product formation was 17 ± 1 s−1 (Table 3), which reflects an 18-fold
increase in activity as compared to that of 1Zn-L1. Previous EXAFS
studies on L1 demonstrated that there is sequential binding of Zn(II)
to apo-L1 and that the first equivalent of Zn(II) binds to the Zn1 site.28
This result coupled with the stopped-flow traces described above
indicates that metal ions in both of the metal binding sites are required
for the stabilization and observation of the reaction intermediate when
nitrocefin is used as a substrate.
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Figure 3. Stopped-flow traces of the reaction of Zn(II)-containing L1 analogues and
nitrocefin. Stopped-flow traces of 50 μM 1Zn-L1 (A) and ZnZn-L1 (B) analogues when
reacted with 50 μM nitrocefin at 4 °C. The absorbance at 485 nm is due to the
product, the absorbance at 390 nm is due to the substrate, and the absorbance at 665
nm is due to the intermediate.54

Table 3. Exponential Fits to the Stopped-Flow Kinetic Data
species

rate of product formation (s−1)a

1Zn-L1

0.92 ± 0.03

ZnZn-L1

17 ± 1

1Co-L1

0.05 ± 0.01

ZnCo-L1

12 ± 1

ZnFe-L1

12 ± 1

0.12 ± 0.02
1Fe-L1
aRates determined by exponential fitting of the stopped-flow data in Figures 3, 4, and
7.

Stopped-flow studies were also conducted on the Co(II)containing samples. The stopped-flow trace for 1Co-L1 showed that
substrate decay took over 10 s and that no intermediate formed
(Figure 4A). The rate of product formation was 0.05 ± 0.01 s−1 (Table
3). This result is not consistent with the steady-state kinetic results
that showed that 1Co-L1 is very active (Table 2) and suggests that
most of the activity observed in the steady-state kinetic studies was
due to the ZnCo analogue of L1. The stopped-flow trace for ZnCo-L1
(Figure 4B) showed that substrate depleted as fast as it did for ZnZnL1 (Figure 3B), and the rate of product formation was 12 ± 1 s−1
(Table 3), which reflects a 240-fold increase in activity over that of
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1Co-L1. There is a 1.4-fold decrease in the amount of intermediate
formed for ZnCo-L1, as compared to that for ZnZn-L1; however, there
is a 1.4-fold increase in the amount of intermediate formed for ZnCoL1 as compared to that for CoCo-L1 (Figure 5). The intermediate
decays faster in the reaction with ZnZn-L1, as compared with CoCoand ZnCo-L1, and the rates of intermediate decay for CoCo- and
ZnCo-L1 are very similar. This result, along with the results described
above, strongly indicates that cobalt binds to the Zn2 site and that the
Zn2 site is involved in stabilizing the intermediate.

Figure 4. Stopped-flow traces of the reaction of Co(II)-containing L1 analogues with
nitrocefin. 50 μM 1Co- (A) and ZnCo-L1 (B) analogues were reacted with 50 μM
nitrocefin at 4 °C. The absorbance at 485 nm is due to the product, the absorbance at
390 nm is due to the substrate, and the absorbance at 665 nm is due to the
intermediate.
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Figure 5. Intermediate formation by L1 analogues. The absorbance at 665 nm arises
from the presence of intermediate. Each reaction contained 50 μM L1 analogue and 50
μM nitrocefin at 4 °C in 50 mM cacodylate buffer, pH 7.0. (Inset) Intermediate
formation for ZnZn-, ZnCo-, and CoCo-L1 analogues over 200 ms.

RFQ-EPR studies
EPR spectra recorded on ZnCo-L1 during an RFQ-EPR
experiment are shown in Figure 6. The resting signals from ZnCo-L1
recorded at 10 K, 2 mW (Figure 6A) and at 7 K, 80 mW (Figure 6B)
were very similar and are due to two isolated S = 3/2, MS = ±1/2
systems. These systems are in turn due to Co(II) in either of the
binding sites in singly occupied L1. Upon reaction with nitrocefin for 10
ms, the color of the sample became bright blue, and the EPR spectra
shown in Figure 6C−E were observed. At 10 K, 2 mW (Figure 6C), the
inflections in the spectrum (1600−2000 G), due to the presence of the
isolated rhombic species of Figure 2A, were no longer observable, and
instead a small but distinct sharp peak at 1025 G (geff = 6.65) was
observed. At successively higher microwave power and lower
temperature, this signal became more prominent as other features
were lost to saturation and rapid-passage effects (Figure 6D, E),
characteristic of an MS = ±3/2 system and of tetrahedral Co(II). Upon
further reaction, the sample turned red, indicating the hydrolysis of
nitrocefin, and new EPR signals were observed (Figure 6F,G) that are
presumably due to a product complex. These signals showed no
evidence of an MS = ±3/2 component but were unusual in that the gz
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feature at 2650 G (geff = 2.6) was very well-resolved, indicative of
constrained geometry and consistent with binding of Co(II) to a more
rigid ligand than water.32

Figure 6. RFQ-EPR of ZnCo-L1 with nitrocefin. Spectra (A) and (B) are from resting
ZnCo-L1. Spectra (C−E) are from ZnCo-L1 after reaction with nitrocefin for 10 ms at
3 °C. Spectra (F) and (G) are from ZnCo-L1 after incubation with nitrocefin for 2 min
(at which time all of the added nitrocefin has been hydrolyzed). Spectra (A), (C) and
(F) were recorded at 10 K, 2 mW, spectra (B), (D) and (G) at 7 K, 80 mW, and
spectrum (E) at 5 K, 126 mW. Spectra are shown with arbitrary intensities.

Preparation and Characterization of the ZnFe-Analogue
of L1
Our ability to prepare a mixed-metal analogue of L1 by using a
biological incorporation method led us to speculate whether a ZnFe
analogue of L1 could also be prepared. Recently, our studies using the
overexpression plasmid that results in L1 being folded in the cytoplasm
allowed us to prepare an iron-containing analogue of L1.18 However,
the FeFe-L1 analogue was catalytically inactive. In an effort to prepare
a ZnFe analogue of L1, we overexpressed L1 in minimal medium
containing 100 μM Fe(II). The purified enzyme was green in color,
contained 0.9 equiv of Fe and 0.2 3 of Zn(II), and exhibited a kcat of
2.6 s−1 and a Km of 53 μM, when using nitrocefin as the substrate. The
addition of 0.8 equiv of Zn(II) resulted in a sample that exhibited a kcat
of 24 s−1 and a Km of 4 μM (Table 2).
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The EPR signal of 1Fe-L1 (Figure 2F) consisted of two types of
signals. A rhombic S = 5/2 signal was observed with resonances at geff
≈ 9 and ≈ 4.3, and with some structure in the g ≈ 4.3 region
indicative of protein-bound Fe(III). The other contribution was from
two very similar and largely overlapping signals with geff < 2
(3400−4000 G) and indicative of an antiferromagnetically coupled
Fe(II)−Fe(III) dinuclear site.33,34 Spin quantitation35 of these signals
suggests that 50% of iron is from a mononuclear Fe(III) center, while
50% is from Fe(III)Fe(II) or Fe(II)Fe(III) centers. The amount of
signal corresponding to Fe(III)Fe(II) (or Fe(II)Fe(III)) varied among
samples, and the amount of the antiferromagnetically coupled centers
was greatest in the sample corresponding to Figure 2F. More typically,
we obtained spectra that contained only ∼10% of the signal due to the
spin-coupled center, perhaps due to oxidation of the center to the
EPR-inactive Fe(III)Fe(III) center. Addition of Zn(II) generated ZnFeL1, although the EPR signal varied from sample to sample. In all cases,
there were small but reproducible changes in the Fe(III) signal
(perhaps indicative of formation of an Zn(II)Fe(III) center in some
molecules), and the intensity of the Fe(II)Fe(III) signal diminished,
sometimes by a rather modest amount, as in Figure 2G, and
sometimes almost completely. Spin quantitation35 of the signals in
Figure 2G were consistent with a 25−30% contribution from a spincoupled center and a 70−75% contribution from Fe(III) in a single
site. Further addition of iron, to form FeFe-L1, consistently abolished
the Fe(II)Fe(III) signal (Figure 2H), as did additions of Ni(II) (Figure
2I) and Co(II) (Figure 2J). Additionally, marked changes in the Fe(III)
signals in these bimetallic forms of L1 were observed. The g ≈ 9 and
4.3 regions of the spectrum of FeFe-L1 differ from those of 1Fe-L1 and
ZnFe-L1. Additional transitions were observed flanking the g ≈ 4.3
region of the spectrum of FeNi-L1, indicating a narrowing of the
distribution of E/D due to lowering of strain terms and a more
constrained Fe(III) environment. The shape and intensity change of
the g ≈ 9 feature suggests changes in both strains and in D. In FeCoL1, transitions due to Fe(III) and Co(II) in the region 800−3000 G
could not be deconvoluted with confidence, but the very sharp nature
of the g ≈ 4.3 resonance from Fe(III) again indicates changes in the
zero-field splitting parameters of Fe(III).
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In an effort to further probe which site (Zn1 or Zn2) that the Fe
binds, we attempted to obtain a 1H NMR spectrum of this sample;
however, no peaks were observed between −200 to +200 ppm. We
believe that the inability to observe any peaks in this sample is due, in
part, to the relatively slow electron spin relaxation rate (T1e) of highspin Fe(III) and the large size (118 kDa) of L1, both of which result in
significant broadening of 1H NMR peaks.36 Our inability to observe
paramagnetically shifted resonances due to the spin-coupled
Fe(III)Fe(II) centers in the L1 samples is most likely due to the
presence of a single bridging group (hydroxide) in this analogue and
different relaxation properties as compared to similar centers in GLX25.33
The ZnFe-analogue of L1 was also prepared by adding 1 equiv
of Fe(II) directly to 1Zn-L1, which was made by adding 1 equiv of
Zn(II) directly to apo-L1. This sample exhibited steady-state kinetic
constants almost identical to those of the sample described above
(Table 2). Similar to the results on cobalt-containing samples of L1,
the 1Fe-L1 analogue exhibited little or no activity and produced no
intermediate (Figure 7), suggesting the steady-state kinetic data for
this enzyme were due to small amounts of ZnFe-L1. The rate of
product formation for 1Fe-L1 was 0.12 ± 0.02 (Table 3). The stoppedflow traces for ZnFe-L1 showed substrate depletion occurred during
the first 0.08 s and 2.6-fold less intermediate formed for this enzyme
as compared to that for ZnZn-L1 (Figure 7). The rate of product
formation for ZnFe-L1 (made by adding Zn(II) to 1Fe-L1 or by adding
Fe(II) to 1Zn-L1) was 12 ± 1, which reflects a 100-fold increase in
activity as compared to that for 1Fe-L1 (Table 3).
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Figure 7. Stopped-flow traces of Fe-containing L1 analogues reacted with nitrocefin;
50 μM 1Fe- (A), ZnFe-L1 (made by adding Fe(II) to 1Zn-L1) (B), and ZnFe-L1 (made
by adding Zn(II) to 1Fe-L1) (C) were reacted with 50 μM nitrocefin at 4 °C. The
absorbance at 485 nm is due to the product, the absorbance at 390 nm is due to the
substrate, and the absorbance at 665 nm is due to the intermediate.

RFQ-EPR Studies with FeZn-L1 and Nitrocefin
As with ZnCo-L1, the EPR spectrum of ZnFe-L1 was observed to
change upon incubation with nitrocefin for 10 ms at 3 °C (Figure 8).
The various transitions that make up the g ≈ 4.3 line in ZnFe-L1
(Figure 8A) are due to the mean E/D being slightly less than 1/3 and
the strain-dependent distribution in E/D not being large enough to
broaden out all of the transitions. Upon reaction with nitrocefin, the
resonance positions of these partially resolved transitions change,
indicative of a change in E/D and, hence, in the ligand field at Fe(III)
(Figure 8B, G, H). Further change in the g ≈ 9 resonance was
observed (Figure 8C, D), and a shoulder was observed at g ≈ 5 (1350
G Figure 8E, F) upon reaction of ZnFe-L1 with nitrocefin.
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Figure 8. RFQ-EPR of ZnFe-L1 with nitrocefin. Trace A shows the 500−2500 G region
of the spectrum of resting ZnFe-L1. Trace B shows the 500−2500 G region of the
spectrum of ZnFe-L1 upon reaction with nitrocefin for 10 ms at 3 °C (solid line)
overlaid with that of resting ZnFe-L1 (dashed line). The inserts show more detailed
comparisons between the spectra over particular field ranges; traces (C), (F), and (G)
are from resting ZnFe-L1, and traces (D), (E), and (H) are from ZnFe-L1 after reaction
with nitrocefin for 10 ms at 4 °C.

Discussion
Zn(II) plays an essential catalytic role in enzymes from all of the
major classes of enzymes and a structural role in a large number of
other proteins.37-39 Due to its valence electronic configuration of
[Ar]3d, Zn(II) is silent to most spectroscopic techniques. Fortunately,
Zn(II) can be substituted with Co(II), and the resulting enzymes are
catalytically active and contain metal binding sites nearly identical to
those of the Zn(II)-containing analogues.32,40 For mononuclear Zn(II)containing enzymes such as carbonic anhydrase, the Co(II)substituted analogue yields unambiguous results regarding the
function of the metal site in catalysis.41 However in the case of
dinuclear Zn(II)-containing enzymes, the interpretation of
kinetic/spectroscopic results are more complicated due to the presence
of up to three distinct species, [M1_], [_M2] and [M1M2], that can
interact with substrates in distinct ways and that can display
overlapping spectroscopic signatures. Nonetheless, previous studies on
dinuclear metal ion-containing aminopeptidase from Aeromonas
proteolytica demonstrated that mixed-metal ion-containing analogues
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of the enzyme could be used to probe the role of each metal in
catalysis/binding.31,32,42 The metal binding mode of this enzyme is
sequential, which allowed for the preparation and characterization of
the ZnZn, ZnCo (or CoZn), 1Zn, and 1Co analogues. For other
enzymes such as BcII, however, the binding constants of the two
metal binding sites are similar, leading to mixtures of enzyme
containing mononuclear, dinuclear, and even trinuclear metal ioncontaining analogues.13,14 The interpretation of kinetic and
spectroscopic results on such mixtures is difficult if not impossible to
accomplish.
Since the metal binding Kd1 and Kd2 for Zn(II) binding to L1 was
reported to be 2.6 and 6.0 nM,9 respectively, we did not initially
believe that we could prepare enzyme samples containing 1Zn-, 1Co-,
or ZnCo-centers by simply adding the metal ion to metal-free enzyme.
Therefore, our first attempt to prepare these analogues involved the
use of site-directed mutagenesis. The rationale for these studies was
to introduce a mutation in one of the metal binding sites and to
weaken metal binding to this site. Since Asp120 is essential for
catalysis in L1,23 we decided to substitute the metal binding histidines
in the enzyme. Five site-directed mutants, with single point mutations,
were generated; however surprisingly, only two of the resulting
mutants were soluble. Fortunately, there was one HXXC mutation in
each of the metal binding sites (H116C for Zn1 site, H121C for Zn2
site). Steady-state kinetic studies showed that the catalytic activities
of both mutants were low (Table 1), which is consistent with the
observed low Zn(II) incorporation. After incubation with excess Zn(II)
and dialysis to remove loosely bound or nonbound Zn(II), both
mutants were shown to bind nearly 1 equiv of Zn(II), which suggests
that the one amino acid substitution did impair metal binding as
expected. Steady-state kinetic studies conducted in the presence of
100 μM Zn(II) demonstrated that H121C exhibits activity (kcat = 33 ±
3 s−1) similar to that of wild-type L1, although the mutant exhibited a
much higher value for Km. In contrast, the H116C mutant exhibited
almost no activity even in the presence of added Zn(II). Since His161
is in the Zn1 site, this result suggests that the Zn1 site is important for
catalysis; however, we cannot rule out the possibility that the point
mutation did not alter the substrate binding site. These results also
demonstrate that a mutation to one of the metal binding histidines
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results in an enzyme that requires excess metal ion to saturate the
mutated site. Since the excess metal ions would undoubtedly
complicate subsequent spectroscopic analyses, we concluded that this
strategy cannot be used to prepare the mixed-metal analogues of L1.
Consequently, we utilized a biological incorporation strategy in
an attempt to prepare L1 analogues containing only one equivalent of
Co(II) and the mixed metal ion-containing analogues. Overexpression
of L1 in minimal medium containing cobalt resulted in an enzyme that
binds ∼0.9 equiv of Co(II). Spectroscopic studies strongly suggest that
Co(II) is not delocalized between the two metal binding sites and that
it binds to the consensus Zn2 site (Figures 1 and 2). A similar metal
content is obtained when L1 is overexpressed in the presence of Zn(II)
using this same technique. Our previous EXAFS studies28 and recent
crystallographic studies by Dideberg43 demonstrate that Zn(II)
preferentially binds to the Zn1 site. In agreement with the model of
Co(II) binding to the Zn2 site and Zn(II) binding to the Zn1 site, the
addition of 1 equiv of Zn(II) to 1Co-L1 results in an enzyme with EPR
properties almost identical to those of 1Co-L1 (Figure 2B, C); however,
the two analogues exhibit significantly different presteady-state kinetic
behaviors (Figure 4). Surprisingly, a FeZn analogue of L1 can also be
prepared by using the same strategy. EPR studies show that the
resulting 1Fe-L1 contains a predominant ZnFe center; however,
samples also sometimes contained some antiferromagnetically coupled
Fe(III)Fe(II) (Figure 2G). The formation of a ZnFe center was reflected
in differences between the Fe(III) EPR spectra of 1Fe-L1 and ZnFe-L1,
and the narrowing of the spectrum upon incorporation of Zn(II)
suggests increased conformational rigidity of the active site in the
dimetallic form. While the effect of Zn(II) on the EPR signal was quite
subtle, much more dramatic effects were observed with Ni(II) and
Co(II). In both cases a significant reduction in the structural
microheterogeneity of the Fe(III) environment was revealed by EPR,
giving rise to resolved E/D < 1/3 transitions with Ni(II) and a very
sharp E/D = 1/3 g = 4.3 line with Co(II). Interestingly, no spin−spin
exchange coupling was detected in FeCo-L1. Both metal ions in L1 are
required for maximum catalytic activity. Thus, the binding of the
second metal ion fine-tunes the electronic structure of the first ion via
a structural, rather than electronic, mechanism. We were unable to
obtain 1H NMR spectra of the Fe-containing analogues of L1 due to the
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relatively slow T1e of Fe(III)44 and presumably due to the low
concentration of Fe(II)Fe(III) in the sample. Nonetheless, we
hypothesize that Fe(III) is binding to the Zn2 site since the H−H−D
motif is a common Fe(III) binding site in biology.45 Fe(II) can bind at
the Zn1 site, but the addition of Zn(II) to 1Fe-L1 results in a reduction
of the signal corresponding to the mixed-valent, dinuclear iron center
(Figure 2G). The ZnFe analogue can be prepared either by adding Fe
to 1Zn-L1 or Zn(II) to 1Fe-L1, since the resulting enzymes exhibit the
same steady-state and presteady-state kinetic characteristics (Table 2
and Figure 7). Taken together, these results demonstrate that mixedmetal analogues of L1 can be generated and used in mechanistic
studies to probe the role of each metal in catalysis.
Stopped-flow kinetic studies on 1Zn-, 1Co-, ZnZn-, and ZnCo-L1
were used to probe the role of the metal ions. 1Zn-L1, with Zn(II) in
the Zn1 site, exhibited some activity (ZnZn-L1 is 18-fold more active
than 1Zn-L1, Table 3); however, very little intermediate was detected
in these studies (Figure 3). On the other hand, 1Co-L1, with Co(II) in
the Zn2 site, is almost completely inactive (ZnZn-L1 is 340-fold more
active than 1Co-L1, Table 3). It is likely that the small activity
exhibited by 1Co-L1 in the stopped-flow studies (0.29% as compared
to that by ZnZn-L1) is due to small amounts of Zn(II) in 1Co-L1
preparations (Table 1) and in the buffer (estimated to be 100 nM,
which is 0.2% of the concentration of enzyme in the stopped-flow
studies). The 1Fe-L1 analogue was >140-fold less active than ZnZn-L1
(Figures 4 and 7; Table 3), and this higher activity, as compared to
that of 1Co-L1, is mostly due to the higher amounts of Zn(II) in the
1Fe-L1 samples (Table 2). We cannot unambiguously rule out that one
of the Fe-containing analogues of L1 is active, although our studies
indicate that FeFe-L1 is inactive (Table 2).18 These results indicate that
both metal ions are required to detect intermediate in the reaction of
nitrocefin with the ZnCo- and ZnFe-analogues of L1 (Figures 3, 4, 5,
and 7). These results also indicate that an analogue of L1 with metal
(Co(II) or Fe) only in the Zn2 site is inactive. In contrast, an analogue
of L1 with Zn(II) in the Zn1 site does exhibit some activity, albeit very
small (compare rates of product formation for 1Zn-L1 with those of
1Co-L1 and 1Fe-L1; Table 3), and this analogue does allow for the
formation of a small (4%) amount of intermediate (Figure 3A). Taken
together, these results demonstrate that both metal ions in L1 are
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required for maximum catalytic activity. The Zn1 site “prefers” Zn(II)
over any other metal ion, and the role of this metal ion is presumably
to provide the reactive nucleophile during catalysis. L1 analogues with
metal ion only in the Zn2 are not catalytically active. The Zn2 site can
bind a number of metal ions including Co(II) and Fe(III)/Fe(II). The
role of this site is to stabilize the reaction intermediate during
catalysis. This result is consistent with previous suggestions on CcrA46
and on model complex-catalyzed hydrolysis of nitrocefin.47,48 It is not
absolutely essential to have the Zn2 filled in order that L1 be active
since 1Zn-L1 does exhibit some catalytic activity. Based on previous
studies on CcrA,46,49,50 the roles of the metal ions are most like the
same in the subgroup 3A β-lactamase. The results presented above
cannot necessarily be applied to BcII, since there is considerable
controversy presently, regarding whether the mononuclear Zn(II)containing enzyme is active.10,12-14 In addition, Vila and co-workers
have reported that no ring-opened, nitrogen anionic intermediate is
observed when BcII is reacted with nitrocefin.51
The successful preparation of a heterometallic analogue of L1
that contained a paramagnetic metal ion in one metal binding site
allowed us to directly probe the reaction mechanism of L1 with RFQ
EPR studies. The EPR spectrum of ZnCo-L1 was consistent with Co(II)
being 5-coordinate in the resting form of the enzyme (Figure 6A and
B). Within 10 ms reaction time, a 4-coordinate tetrahedral
intermediate, not seen at all in any of the resting spectra from Co(II)containing L1, was formed. This species decayed as substrate was
exhausted, and a higher coordination product complex remained. This
result confirms our previous work that showed that substrate,
intermediate, and product coordinate the metal ion(s) in L1.20 RFQ-EPR
of ZnFe-L1 also showed catalytically competent changes in the EPR
spectrum, here due to Fe(III).
On the basis of all of the data on L1 presented to date, we are in
position to propose a reaction mechanism of nitrocefin hydrolysis by L1
(Figure 9). When nitrocefin binds, the terminally bound water molecule
on Zn2 releases, and the β-lactam carbonyl interacts with the metal ion
in the Zn1 site while the nitrogen lone pair on the nitrogen of the βlactam interacts with Zn2.27,52 The binding of substrate results in the
loss of the Zn2-bridging hydroxide bond, thereby generating a 4Journal of the American Chemical Society, Vol 130, No. 43 (October 29, 2008): pg. 14207-14216. DOI. This article is ©
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coordinate metal ion in the Zn2 site and the reactive nucleophile that is
directed for attack by Asp120.23 The resulting, very short-lived
tetrahedral species is converted to the ring-opened, nitrogen anionic
intermediate after the loss of the β-lactam bond. At this time it is not
clear if one metal ion or both are involved in the stabilization of the
intermediate, but the data in this work clearly show that the metal ion
in the Zn2 site is essential for stabilization. The breakdown of the
intermediate involves a protonation, which likely occurs during the
concerted formation of a new bridging water/hydroxide. Our previous
kinetic studies strongly suggested that Asp120 plays a role in orienting
the acidic proton on the solvent molecule for protonation of
intermediate.23 When other substrates are used, there is evidence that
the reaction intermediate does not accumulate,53 suggesting that ringopening and protonation of the β-lactam nitrogen is concerted.
Regardless of substrate, the EP complex is in equilibrium with the
resting enzyme, and in both cases, the coordination number at the Zn2
site is 5.

Figure 9. Proposed reaction mechanism of L1 for the hydrolysis of nitrocefin.

The successful preparation of mononuclear metal ion-containing
and heterometallic analogues of L1 has allowed us for the first time to
probe the roles of the metal ions in this enzyme. It is clear that the
metal ion in the Zn1 site is essential for activity and that the most
active form of the enzyme requires both metal ions. The metal ion in
the Zn2 site appears to be involved in the stabilization of a reaction
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intermediate and possibly in orienting the β-lactam nitrogen for
protonation. These results demonstrate that potential inhibitors can be
designed to target the Zn1 site only or both sites, although compounds
that bind to the Zn2 site and that block the Zn1 site may also be
effective inhibitors.
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